410 related articles for article (PubMed ID: 19189391)
1. The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model.
Roosa SM; Kemppainen JM; Moffitt EN; Krebsbach PH; Hollister SJ
J Biomed Mater Res A; 2010 Jan; 92(1):359-68. PubMed ID: 19189391
[TBL] [Abstract][Full Text] [Related]
2. Effect of the biodegradation rate controlled by pore structures in magnesium phosphate ceramic scaffolds on bone tissue regeneration in vivo.
Kim JA; Lim J; Naren R; Yun HS; Park EK
Acta Biomater; 2016 Oct; 44():155-67. PubMed ID: 27554019
[TBL] [Abstract][Full Text] [Related]
3. Effect of polycaprolactone scaffold permeability on bone regeneration in vivo.
Mitsak AG; Kemppainen JM; Harris MT; Hollister SJ
Tissue Eng Part A; 2011 Jul; 17(13-14):1831-9. PubMed ID: 21395465
[TBL] [Abstract][Full Text] [Related]
4. Precision extruding deposition (PED) fabrication of polycaprolactone (PCL) scaffolds for bone tissue engineering.
Shor L; Güçeri S; Chang R; Gordon J; Kang Q; Hartsock L; An Y; Sun W
Biofabrication; 2009 Mar; 1(1):015003. PubMed ID: 20811098
[TBL] [Abstract][Full Text] [Related]
5. Repairing a critical-sized bone defect with highly porous modified and unmodified baghdadite scaffolds.
Roohani-Esfahani SI; Dunstan CR; Davies B; Pearce S; Williams R; Zreiqat H
Acta Biomater; 2012 Nov; 8(11):4162-72. PubMed ID: 22842031
[TBL] [Abstract][Full Text] [Related]
6. Improvement of dual-leached polycaprolactone porous scaffolds by incorporating with hydroxyapatite for bone tissue regeneration.
Thadavirul N; Pavasant P; Supaphol P
J Biomater Sci Polym Ed; 2014; 25(17):1986-2008. PubMed ID: 25291106
[TBL] [Abstract][Full Text] [Related]
7. Modified PHBV scaffolds by in situ UV polymerization: structural characteristic, mechanical properties and bone mesenchymal stem cell compatibility.
Ke Y; Wang YJ; Ren L; Zhao QC; Huang W
Acta Biomater; 2010 Apr; 6(4):1329-36. PubMed ID: 19853067
[TBL] [Abstract][Full Text] [Related]
8. Solvent-free polymer/bioceramic scaffolds for bone tissue engineering: fabrication, analysis, and cell growth.
Minton J; Janney C; Akbarzadeh R; Focke C; Subramanian A; Smith T; McKinney J; Liu J; Schmitz J; James PF; Yousefi AM
J Biomater Sci Polym Ed; 2014; 25(16):1856-74. PubMed ID: 25178801
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method.
Oh SH; Park IK; Kim JM; Lee JH
Biomaterials; 2007 Mar; 28(9):1664-71. PubMed ID: 17196648
[TBL] [Abstract][Full Text] [Related]
10. Polycaprolactone- and polycaprolactone/ceramic-based 3D-bioplotted porous scaffolds for bone regeneration: A comparative study.
Gómez-Lizárraga KK; Flores-Morales C; Del Prado-Audelo ML; Álvarez-Pérez MA; Piña-Barba MC; Escobedo C
Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():326-335. PubMed ID: 28629025
[TBL] [Abstract][Full Text] [Related]
11. Biomineral coating increases bone formation by ex vivo BMP-7 gene therapy in rapid prototyped poly(L-lactic acid) (PLLA) and poly(ε-caprolactone) (PCL) porous scaffolds.
Saito E; Suarez-Gonzalez D; Murphy WL; Hollister SJ
Adv Healthc Mater; 2015 Mar; 4(4):621-32. PubMed ID: 25515846
[TBL] [Abstract][Full Text] [Related]
12. Relationship between micro-porosity, water permeability and mechanical behavior in scaffolds for cartilage engineering.
Vikingsson L; Claessens B; Gómez-Tejedor JA; Gallego Ferrer G; Gómez Ribelles JL
J Mech Behav Biomed Mater; 2015 Aug; 48():60-69. PubMed ID: 25913609
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vitro analysis of novel structured nanofibrous scaffolds for bone tissue engineering.
Wang J; Yu X
Acta Biomater; 2010 Aug; 6(8):3004-12. PubMed ID: 20144749
[TBL] [Abstract][Full Text] [Related]
14. An in vivo study on the effect of scaffold geometry and growth factor release on the healing of bone defects.
Yilgor P; Yilmaz G; Onal MB; Solmaz I; Gundogdu S; Keskil S; Sousa RA; Reis RL; Hasirci N; Hasirci V
J Tissue Eng Regen Med; 2013 Sep; 7(9):687-96. PubMed ID: 22396311
[TBL] [Abstract][Full Text] [Related]
15. Highly porous polycaprolactone scaffolds doped with calcium silicate and dicalcium phosphate dihydrate designed for bone regeneration.
Gandolfi MG; Zamparini F; Degli Esposti M; Chiellini F; Fava F; Fabbri P; Taddei P; Prati C
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():341-361. PubMed ID: 31147007
[TBL] [Abstract][Full Text] [Related]
16. Effects of designed PLLA and 50:50 PLGA scaffold architectures on bone formation in vivo.
Saito E; Liao EE; Hu WW; Krebsbach PH; Hollister SJ
J Tissue Eng Regen Med; 2013 Feb; 7(2):99-111. PubMed ID: 22162220
[TBL] [Abstract][Full Text] [Related]
17. Effect of self-assembled nanofibrous silk/polycaprolactone layer on the osteoconductivity and mechanical properties of biphasic calcium phosphate scaffolds.
Roohani-Esfahani SI; Lu ZF; Li JJ; Ellis-Behnke R; Kaplan DL; Zreiqat H
Acta Biomater; 2012 Jan; 8(1):302-12. PubMed ID: 22023750
[TBL] [Abstract][Full Text] [Related]
18. Surface modification of porous polycaprolactone/biphasic calcium phosphate scaffolds for bone regeneration in rat calvaria defect.
Kim JH; Linh NT; Min YK; Lee BT
J Biomater Appl; 2014 Oct; 29(4):624-35. PubMed ID: 24939961
[TBL] [Abstract][Full Text] [Related]
19. Solid free-form fabrication-based PCL/HA scaffolds fabricated with a multi-head deposition system for bone tissue engineering.
Kim JY; Lee TJ; Cho DW; Kim BS
J Biomater Sci Polym Ed; 2010; 21(6-7):951-62. PubMed ID: 20482995
[TBL] [Abstract][Full Text] [Related]
20. The effects of pore size in bilayered poly(lactide-co-glycolide) scaffolds on restoring osteochondral defects in rabbits.
Duan P; Pan Z; Cao L; He Y; Wang H; Qu Z; Dong J; Ding J
J Biomed Mater Res A; 2014 Jan; 102(1):180-92. PubMed ID: 23637068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
